Clinical Trials Ontario CTO Streamlined Research Ethics Review System
|
|
|
- Theresa Horton
- 8 years ago
- Views:
Transcription
1 Clinical Trials Ontario CTO Streamlined Research Ethics Review System Making Ontario a preferred location for global clinical trials, while maintaining the highest ethical standards.
2 About Clinical Trials Ontario Clinical Trials Ontario (CTO) is an independent, not-for-profit organization. Established in 2012 with seed funding from the Government of Ontario $4.5 million over 4 years in response to: Significant decline in clinical research in Ontario 2009: $550m 2010: $500m 2011: $438m (pharma investment) Stakeholder recommendations regarding what would help Mandate for CTO provide a streamlined approach to conducting multi-centre clinical trials in Ontario while maintaining the highest ethical standards for participant protection.
3 The Vision of Clinical Trials Ontario The vision of CTO is being advanced upon 3 strategic pillars: 1. Improving speed and reducing costs of multi-centre clinical trials by streamlining the research ethics approval process and harmonizing other administrative processes and platforms. 2. Attracting clinical trial investments to Ontario based on CTO s success in streamlining activities and by leveraging strategic partnerships with investigators, industry and government to access global decision makers. 3. Improving participant recruitment and retention through education, and by engaging participants and the public in recognizing the benefits of clinical trials.
4 The CTO Streamlined Research Ethics Review System
5 The CTO Streamlined Research Ethics Review System Supports any CTO Qualified REB in Ontario in providing ethics review and oversight of a multi-centre clinical trial on behalf of multiple research sites across the province. Two Primary Components 1. Research Ethics Board (REB) Qualification Program Offers external review and qualification of REBs against a standard (i.e. checklist) informed by regulations/guidelines applicable to ethics review of clinical/health research Required for any REBs participating in the CTO Streamlined Research Ethics Review System Qualification Reviews conducted by a team composed of an REB auditor and experienced members of the REB community (see College of Reviewers) Qualified Status remains in effect for 3 years (with brief annual reports)
6 The CTO Streamlined Research Ethics Review System 2. Research Ethics Board (REB) Qualification Program Based on delegated board of record model ; a Qualified REB is delegated by participating institutions the responsibility to provide ethical oversight for a study conducted across multiple institutions one study, one REB Infrastructure includes web-based information technology system, policies and procedures, tools and education To obtain the CTO REB Qualification Manual and other info about the Qualification Program, visit ctontario.ca
7 Key Features of the CTO Research Ethics Review System The CTO System is expected to provide significant benefits to sponsors, investigators, institutions and REBs conducting multi-centre clinical research by harmonizing processes and reducing time and effort required to initiate research across multiple sites in Ontario. Supports a single REB in providing research ethics review and oversight to multiple research sites Can be used for any multi-site clinical research, i.e. industry sponsored or investigator initiated Offers a web-based information technology system that will enable research ethics reviews, document management and communication across multiple REBs and institutions Ensures that all REB reviews done through the CTO system are conducted by high-quality REBS that have achieved Qualification status Investigators/applicants will use the same interface and REB application forms, irrespective of which REB is providing oversight Consistency in submission requirements Timely and reliable distribution of study events (e.g. safety updates, amendments) between the REB and multiple institutions Transparent and timely information to applicants regarding REB review status
8 Delegated Board of Record Model Initial Application Process Step 1: Applying for a New Multi-Centre Clinical Trial Step 2: Adding New Investigators/ Research Sites REB application submitted by any registered investigator/site, i.e. Provincial Applicant CTO assigns Board of Record (any Qualified REB in Ontario) and advances application Site adopts approved Informed Consent Form. Submits site application focused on site specific information Site application advances to Board of Record Board of Record reviews application and resolves any issues with applicant Once issues are resolved Board of Record approves study Board of Record reviews application (usually expedited) and resolves any issues with site applicant Participating sites are notified and given access to REB materials in CTO system Board of Record issues approval for site to participate
9 Delegated Board of Record Model Continuing Oversight and Approval New overall (study-level) event, e.g. amendment, Data Safety Monitoring Board report, safety update New site level event, e.g. continuing (annual) review, local Serious Adverse Event, protocol deviation Documentation submitted by Provincial Applicant Documentation submitted by research site Board of Record reviews submission and resolves issues with prov. applicant Board of Record reviews submission and resolves issues with research site Once issues are resolved, approval or acknowledgement is issued by Board of Record and sent simultaneously to all approved participating sites Approval or acknowledgement issued by Board of Record
10 Supports for the CTO Streamlined Research Ethics Review System College of Reviewers Members of the College will serve a minimum 2 year term, and participate in up to a maximum of 3 REB reviews/year. Members will require Tri-Council Policy Statement (TCPS 2) training, and at least one member of the Qualification Review team will have Good Clinical Practice (ICH-GCP) and Health Canada Food and Drugs Regulation (FDR) Division 5 training. Common Application Forms Common set of application forms for research ethics review have been developed Based on the common elements identified through a national survey of forms (SPOR-SHRER), and advice from CTO Research Ethics Advisory Group and e-forms Working Group, composed of REB operations experts from across Ontario REB Standard Operating Procedures REBs must have Standard Operating Procedures (SOPs) in place in order to undergo a Qualification Review. CTO providing arms-length support for Networks of Networks (N2) / Canadian Association of Research Ethics Boards (CAREB) commitment to develop standard REB SOPs
11 Community Engagement in Building CTO Our industry, hospital, university, research, and research ethics communities continue to collaborate with CTO in the development and implementation of our programming. Our community is building CTO with us. Advisory Groups and Committees CTO Working Groups: REB Streamlining IT Harmonization and Performance Metrics Legal and Liability Research Ethics Review Advisory Group Technical and REB Operational Group ereb RFP Evaluation Committee E-forms Working Group mcta Ontario Team Patient Engagement Advisory Group Industry Advisory Committee
12 CTO Board of Directors and Member Representatives Board of Directors Arthur Slutsky (Chair) Vice-President, Research, St. Michael s Hospital Institutional Member Representatives Council of Academic Hospitals of Ontario (CAHO) Karen Michell, Executive Director Mark Lundie (Vice-Chair and Secretary) Regional Director, R&D, Pfizer Canada Michael Owen (Treasurer) Vice-President, Research, Innovation & International, UOIT Raphael Saginur Chair, Ottawa Health Science Network Research Ethics Board James Wilson President, Brancorth Medical Inc. Anne Ellis Associate Professor and Chair, Department of Medicine, Queen s University Clive Ward-Able Executive Director, R&D, Amgen Canada s Medical Technology Companies (MEDEC) James Wilson, President, Brancorth Medical Inc. Canada s Research-based Pharmaceutical Companies (Rx&D) Jared Rhines, Vice President, Scientific and Strategic Affairs Industrial Biotechnology Association of Canada (BIOTECanada) Alison Vanlerberghe, Director, Market Access, Celgene Council of Ontario Faculties of Medicine (COFM) Alison Buchan, Vice Dean Research and International Relations, Faculty of Medicine University of Toronto Ontario Council on University Research (OCUR) Michael Owen, Vice-President, Research, Innovation & International, University of Ontario Institute of Technology Raphael Hofstein Chief Executive Officer and President, MaRS Innovation Michael Wood Director, Office of Research & Innovation, North York General Hospital
13 Building CTO CTO Team Susan Marlin, President and CEO Manal Siddiqui, Manager Jessa Gill, ereb Project Manager Suzanne McGovern, Program Coordinator Andrew Milroy, Program Coordinator Margaret Polanyi, Senior Communications Specialist (part-time) Sean Power, Communications Specialist (part-time) Anita Sengar, Lead REB Qualification Program Auditor (part-time) Delilah Ofosu-Barko, REB Qualification Program Auditor (part-time) Community Expertise Janet Manzo, Executive Director OCREB (Multi-centre ethics review expertise) Lam Pho, Director of IT, NCIC CTG (IT & Multi-centre clinical trials expertise) Terry Liu, Sr. Business Systems Analyst, OCREB (Multi-centre ethics review systems implementation expertise) Teddy Brown - Programming Support Lorelei Nardi, REB Program Manager at the Hospital for Sick Children (REB operations expertise) Erika Basile, Director, Research Ethics, Western University (REB operations expertise) Linda Bennett, Executive Director, Canadian Rheumatology Research Consortium (Participant Engagement/Asset Map) Chris Riddle, Governance/Board Support Andy Scotter, Procurement Specialist, Queen s University Kevin Cheung, Sunnybrook Health Sciences Centre (IT/RFP expertise)
14 For More Information Go to ctontario.ca To find out more about the CTO Streamlined System, contact us at To request Qualification status or learn more about the Qualification Program, write to us at: Sign up to receive our linkedin.com/company/clinical-trials-ontario Clinical Trials Ontario 661 University Avenue, Suite 460 MaRS Centre, West Tower Toronto, Ontario Canada M5G 1M1 Tel /
Clinical Trials Ontario
Clinical Trials Ontario Streamlined Research Ethics Review System Erin Bell, Program Coordinator June 6-7, 2016 CLINICAL TRIALS ONTARIO Independent non-profit, established in June 2012 and funded by the
OCREB Governance Committee Meeting Friday November 13, 2014 660 University Ave, Suite 501, Toronto, Ontario Meeting Minutes
Cancer Research Ethics Board MaRS Centre, South Tower, Suite 800 101 College Street Toronto, Ontario, Canada M5G 0A3 416-673-6649 www.ocreb.ca OCREB Governance Committee Meeting Friday November 13, 2014
The Ontario Cancer Research Ethics Board Overview
The Ontario Cancer Research Ethics Board Overview Research Ethics Research ethics review is vital to the advancement of ethically sound research. Before individuals can be enrolled in a research study,
Clinical Trials Ontario
Clinical Trials Ontario Making Ontario a preferred location for global clinical trials, while maintaining the highest ethical standards Susan Marlin, President and CEO February 5, 2016 OCHSU CLINICAL TRIALS
Making Ontario a Preferred Location for Global Clinical Trials
Making Ontario a Preferred Location for Global Clinical Trials Clinical Trials Ontario Inaugural Strategic Plan 2012 2017 Strategic Plan Table of Contents LIST OF ABBREVIATIONS... 3 EXECUTIVE SUMMARY...
CTO 2014 CLINICAL TRIALS CONFERENCE February 27, 2014
CTO 2014 CLINICAL TRIALS CONFERENCE February 27, 2014 1 2 7 16 21 26 28 CONTENTS INTRODUCTION EVOLVING CHALLENGES AND OPPORTUNITIES FOR CLINICAL TRIALS Experts Discuss Fundamental Issues Driving Challenges
CORPORATE POLICY AND PROCEDURE MANUAL MANUEL DES POLITIQUES ET PROCÉDURES DE L HOPITAL D OTTAWA
CORPORATE POLICY AND PROCEDURE MANUAL MANUEL DES POLITIQUES ET PROCÉDURES DE L HOPITAL D OTTAWA OTTAWA HEALTH SCIENCE NETWORK RESEARCH ETHICS BOARD GOVERNANCE POLICY SECTION : / NO. / N : BOARD POLICY
Health Canada s GCP Compliance Program. GCP Information Sessions November 2010
Your Health and Safety... Our priority Votre santé et votre Securité notre priorité Health Canada s GCP Compliance Program GCP Information Sessions November 2010 Objective To describe the role that Health
BUSINESS SECTOR STRATEGY:
BUSINESS SECTOR STRATEGY: MEDICAL TECHNOLOGY Created with: MEDEC - CANADA S MEDICAL TECHNOLOGY COMPANIES February 2011 Open for Business is Ontario s initiative to create faster, smarter and streamlined
The Canadian Clinical Trials Asset Map (CCTAM) Jared Rhines,
The Canadian Clinical Trials Asset Map (CCTAM) Jared Rhines, Vice President, Scientifics and Strategic Affairs, Canada s Research-Based Pharmaceutical Companies (Rx&D) Global Patient Recruitment by Region
New Investigator Collaborations and Interactions: Regulatory
Your Health and Safety... Our priority Votre santé et votre Securité notre priorité New Investigator Collaborations and Interactions: Regulatory NCIC Clinical Trials Group New Investigator Clinical Trials
A Clinical Research Coordinator for an International Study THE GYMNAST
A Clinical Research Coordinator for an International Study THE GYMNAST Anita Ng Research Coordinator The Scarborough Hospital May 12, 2007. 1. What is Research? 2. Characteristics of a Clinical Research
Professional Standards and Guidelines
College of Physicians and Surgeons of British Columbia Professional Standards and Guidelines Conflict of Interest Arising from Clinical Research Preamble This document is a guideline of the Board of the
Role of IRB/IEC in GCP. Benjamin Kuo, MD, Dr.PH, CIP.
Role of IRB/IEC in GCP Benjamin Kuo, MD, Dr.PH, CIP. Institutional Review Board (IRB) An independent body constituted of medical, scientific and non scientific members Responsible for ensuring protection
How To Ensure Health Information Is Protected
pic pic CIHI Submission: 2011 Prescribed Entity Review October 2011 Who We Are Established in 1994, CIHI is an independent, not-for-profit corporation that provides essential information on Canada s health
Re. Bill 126, Road Safety Act Submission to the Standing Committee on General Government
425 University Avenue, Suite 502 Toronto ON M5G 1T6 Tel: (416) 595-0006 Fax: (416) 595-0030 E-mail: mail@alphaweb.org Providing leadership in public health management February 18, 2009 Mr. Trevor Day Clerk,
OPPORTUNITY PROFILE. Associate Dean Executive Education
OPPORTUNITY PROFILE Associate Dean Executive Education THE ORGANIZATION - ALBERTA SCHOOL OF BUSINESS EXECUTIVE EDUCATION The Alberta School of Business is one of the world s leading institutions in business
Clinical Research Professional Certification & Preparing for the CCRP Exam
Clinical Research Professional Certification & Preparing for the CCRP Exam Signe Denmark, MS, CCRP Toni Mauney, CCRP SoCRA: Society of Clinical Research Associates SoCRA established the Certification Program
CREDIT UNION CENTRAL OF CANADA NNUAL OVERNANCE REPORT
CREDIT UNION CENTRAL OF CANADA 20 13 NNUAL OVERNANCE REPORT CREDIT UNION CENTRAL OF CANADA The 2013 Board of Directors 2013 Annual Governance Report Daniel Burns, Chair Central 1 Credit Union Graham Wetter,
Membership Recruitment and Selection Process
Public Health Ontario Ethics Review Board Membership Recruitment and Selection Process 1.0 Background In June 2012 Public Health Ontario s (PHO) Board of Directors approved the policy on research involving
CURRICULUM VITA. Resident in the Family Practice Program at the University of British Columbia, 1974-1976.
CURRICULUM VITA Name: Citizenship: Education: Dr. Shelley Nan Ross Canadian Primary and secondary school education in Calgary, Alberta, graduating from James Fowler High School with Honours with Distinction
Health Care Job Information Sheet #20. Clinical Research
Health Care Job Information Sheet #20 Clinical Research A. Background B. Occupations 1) Clinical Research Associate (Study Monitor) 2) Clinical Research Coordinator 3) Other positions in the field C. Labour
Institutional Quality Assurance Process. University of Ottawa
Institutional Quality Assurance Process University of Ottawa June 27, 2011 Table of Contents 1. INTRODUCTION...1 1.1 Authorities...1 1.2 Contact person...1 1.3 Definitions...1 1.4 Evaluation of programs...2
The EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Norway
The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Norway Question 1: What laws or regulations apply to an application for conducting a clinical
This section provides an overview of hospital management and includes detailed descriptions for various physician leadership positions.
OVERVIEW This section provides an overview of hospital management and includes detailed descriptions for various physician leadership positions. HOSPITAL MANAGEMENT Appendix 2 contains basic management
The Hospital for Sick Children 2012-2015 Accessibility Plan. Last Revised: December, 2012
The Hospital for Sick Children 2012-2015 Accessibility Plan Last Revised: December, 2012 1 SickKids Accessibility Plan Table of Contents 1. The Hospital for Sick Children 2. Aim and Objectives of Accessibility
ROLES, RESPONSIBILITIES AND DELEGATION OF DUTIES IN CLINICAL TRIALS OF MEDICINAL PRODUCTS
ROLES, RESPONSIBILITIES AND DELEGATION OF DUTIES IN CLINICAL TRIALS OF MEDICINAL PRODUCTS STANDARD OPERATING PROCEDURE NO SOP 09 DATE RATIFIED 4/7/13 NEXT REVIEW DATE 4/7/14 POLICY STATEMENT/KEY OBJECTIVES:
Food and Drug Regulations Project Number 1623 Schedule F
Graham Spry Building 250 Lanark Avenue Address Locator: 2005D Ottawa, Ontario K1A 0K9 09-118361-538 Provincial and Territorial Deputy Ministers of Health Provincial and Territorial Drug Program Managers
Document Title: Trust Approval and Research Governance
Document Title: Trust Approval and Research Governance Document Number: SOP034 Staff involved in development: Job titles only Document author/owner: Directorate: Department: For use by: RM&G Manager, R&D
Written standards. Agenda
GSK Ethics & Compliance Program US Operations INTRODUCTION GlaxoSmithKline (GSK) is one of the world s leading research-based pharmaceutical and healthcare companies. GSK s global mission is to improve
Request for Applications
Office of Integrated Medical Education Faculty of Medicine, University of Toronto Educational Information Technology (EIT) Summer Student Program Award 2015 Request for Applications Introduction Educational
Office of Clinical Research and the. Institute (CTSI) Patricia Emmanuel, MD
Office of Clinical Research and the Clinical and Translational Research Institute (CTSI) Patricia Emmanuel, MD Office of Clinical Research- Priorities Review processes for clinical study implementation,
Health Products and Food Branch. www.hc-sc.gc.ca
Health Products and Food Branch 1 HEALTH CANADA PART C DIVISION 5 - DRUGS FOR CLINICAL TRIALS INVOLVING HUMAN SUBJECTS Part C - Division 5 2 Part A: Part B: Part C: Part D: Part E: Part G: Part J: Administration
Industry Experience in Clinical Trials Management. Catherine Lee Area Head Clinical Operations Asia Pfizer Inc 20 May 2011 Brussels
Industry Experience in Clinical Trials Management Catherine Lee Area Head Clinical Operations Asia Pfizer Inc 20 May 2011 Brussels Stakeholders in clinical research Critical activities to ensure patient
The Monitoring Visit. Denise Owensby, CCRP Sr. Clinical Research Coordinator Clinical & Translational Science Center University of California, Davis
The Monitoring Visit Denise Owensby, CCRP Sr. Clinical Research Coordinator Clinical & Translational Science Center University of California, Davis Disclosure The information herein is not intended to
CHARTER OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS
CHARTER OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS PURPOSE The Audit Committee (the Audit Committee ) is appointed by the Board of Directors (the Board ) of NVIDIA Corporation, a Delaware corporation
Re: Industry Canada Consultation on the Canada Business Corporations Act (the Consultation )
May 9, 2014 Director General Marketplace Framework Policy Branch Industry Canada 235 Queen Street, 10 th Floor Ottawa, Ontario K1A 0H5 e-mail: cbca-consultations-lcsa@ic.gc.ca Re: Industry Canada Consultation
ST. MICHAEL S HOSPITAL Guidelines for Reporting Serious Adverse Events / Unanticipated Problems to the SMH Research Ethics Board (REB) July 09, 2014
ST. MICHAEL S HOSPITAL Guidelines for Reporting Serious Adverse Events / Unanticipated Problems to the SMH Research Ethics Board (REB) July 09, 2014 1. Introduction The St. Michael s Hospital (SMH) REB
The Centre for the Study of Ministry: Governance and Administrative Structure
The Centre for the Study of Ministry: Governance and Administrative Structure The text of the proposal was approved by the Toronto School of Theology's Board of Trustees June 9, 2009. Summary This is a
PARTICIPATION AGREEMENT REGARDING THE IMPLEMENTATION OF A CANADA~WIDE INSURANCE OF PERSONS (LIFE AND HEALTH) QUALIFICATION PROGRAM
PARTICIPATION AGREEMENT REGARDING THE IMPLEMENTATION OF A CANADA~WIDE INSURANCE OF PERSONS (LIFE AND HEALTH) QUALIFICATION PROGRAM This agreement ("Participation Agreement" or "this Agreement") is made
Ethics and Scientific Oversight for Phase 1 Clinical Trials in Hong Kong. Sydney TANG Chairman, HKU/HA HKW IRB November 21, 2015
Ethics and Scientific Oversight for Phase 1 Clinical Trials in Hong Kong Sydney TANG Chairman, HKU/HA HKW IRB November 21, 2015 Clinical Trials at HKU Phase 1 Phase II Phase III Phase IV Conducted on patient
2015/2016. Heart and Stroke Foundation New Investigator Awards Guidelines Alberta. (Winter 2014 Competition)
2015/2016 Heart and Stroke Foundation New Investigator Awards Guidelines Alberta (Winter 2014 Competition) November, 2014 Heart and Stroke Foundation New Investigator Awards in Alberta The Heart and Stroke
OPPORTUNITY PROFILE. Director, Executive Education Programs. Alberta School of Business - Associate Dean, Executive Education
OPPORTUNITY PROFILE Director, Executive Education Programs 1 THE ORGANIZATION ALBERTA SCHOOL OF BUSINESS EXECUTIVE EDUCATION The Alberta School of Business is one of the world s leading institutions in
Consolidated I&T Data Centre - P3 Canada Fund
STAFF REPORT ACTION REQUIRED Consolidated I&T Data Centre - P3 Canada Fund Date: January 16, 2012 To: From: Wards: Reference Number: Government Management Committee Deputy City Manager & Chief Financial
Approved and Effective as of 28 February 2011 THE ALBERTA HEALTH SERVICES MEDICAL STAFF BYLAWS
Approved and Effective as of 28 February 2011 THE ALBERTA HEALTH SERVICES MEDICAL STAFF BYLAWS Table of Contents DEFINITIONS... 3 PART 1 GENERAL PROVISIONS... 9 1.0 General... 9 1.2 Binding Effect... 10
Corporate Purchasing. Manual: Organizational Approved By: President & C.E.O. Section: Finance Original Date Issued: March 2011
Corporate Purchasing Manual: Organizational Approved By: President & C.E.O. Section: Finance Original Date Issued: March 2011 Reviewed/Revised Date: Revised Reviewed December 2011 PREAMBLE The Pembroke
The Canadian Public Policy Forum (PSPF)
EXECUTIVE DEVELOPMENT About Canada s Public Policy Forum The Public Policy Forum is an independent, not-for-profit organization dedicated to improving the quality of government in Canada through enhanced
PHIA GENERAL INFORMATION
To: From: Researchers Legal Services and Research Services Date: May 21, 2013 Subject: Research and the New Personal Health Information Act On June 1, 2013, the Personal Health Information Act ( PHIA )
Wednesday, October 6. Pre-Conference Activities. 1:30 5:00 Physician Workforce: Using Data for Better Planning. Thursday, October 7
8 th International Medical Workforce Collaborative Preliminary Program Schedule Wed. October 6, 2004 to Saturday October 9, 2004 Mayflower Hotel Washington DC, USA Wednesday, October 6 Pre-Conference Activities
Social Sciences and Humanities Research Council of Canada
Social Sciences and Humanities Research Council of Canada Annex to the Statement of Management Responsibility including Internal Control over Financial Reporting (Unaudited) Fiscal year 2014-15 Table of
The Regulatory Binder/Trial Master File: Essential Records for the Conduct of a Clinical Trial
The Regulatory Binder/Trial Master File: Essential Records for the Conduct of a Clinical Trial Clinical Research Operations & Regulatory Support (CRORS) Ann Glasse, RN, BSN, MBA Director-CRORS Objectives
Humber College Institute of Technology & Advanced Learning. Program Advisory Committee. Procedure Manual
Humber College Institute of Technology & Advanced Learning Program Advisory Committee Procedure Manual Message from the President On behalf of Humber College Institute of Technology & Advanced Learning,
Corporate Governance Guidelines
Corporate Governance Guidelines A. Introduction The Board of Directors (the Board ) of (the Company ) has adopted these corporate governance guidelines to provide a framework within which the Board may
Academic health centers continue to assess,
Elaine Rubin, PhD, and Danielle Lazar, MA Little uniformity exists in structure or functions; models needed for future Academic health centers continue to assess, change, and improve clinical research
OneMatch National. Sue Smith, Executive Director, Stem Cells 2011-11- 04
OneMatch National Public Cord Blood Bank Blood Matters 2011 Sue Smith, Executive Director, Stem Cells 2011-11- 04 No Disclosures To Declare The presenter does not have any involvement with the industry
An Action Plan to Help Attract More Clinical Trials to Canada
An Action Plan to Help Attract More Clinical Trials to Canada To Your Health & Prosperity... March 30, 2012 Updated with an Appendix Reflecting Feedback on Final Draft To Your Health & Prosperity...An
Cancer Clinical Trials. Canadian Dream Team Supplementary Funding
SU2C Canada-OICR Cancer Clinical Trials Canadian Dream Team Supplementary Funding Call for Ideas and Full Application Guidelines 9861 Leslie St Richmond Hill, ON L4B 3Y4 416-797-5366; 905-883-6800 (FAX)
The Study Site Master File and Essential Documents
The Study Site Master File and Essential Documents Standard Operating Procedure Office of Health and Medical Research Queensland Health SOP reference: 002 Version number: 1 Effective date: 01 June 2010
Distributel Communications Limited. c/o Privacy Officer 177 Nepean St. Suite 300, Ottawa, ON, K2P 0B4. January 20, 2014
Distributel Communications Limited. c/o Privacy Officer 177 Nepean St. Suite 300, Ottawa, ON, K2P 0B4 January 20, 2014 Dear Distributel Privacy Officer: We are academic researchers and civil rights organizations
The EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2012) Sweden
The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe Sweden Question 1: What laws or regulations apply to an application for conducting a clinical trial in Sweden?
Donna Woolcott, PhD Executive Director, Quality Assurance
Donna Woolcott, PhD Executive Director, Quality on Quality MAY 7, 2012 UNIVERSITY OF WINDSOR Overview of quality assurance R International context R Ontario context Quality Council mandate Key elements
Job Profile Clinical Research Associate III (CRA)
PART 1 - PROFILE You are an experienced CRA with a strong background in Clinical Research who is passionate about drug development and are seeking a challenging and rewarding career in a quality focussed
Clinical Trials and Safety Surveillance of Drugs in Development
Clinical Trials and Safety Surveillance of Drugs in Development Hoda Eid, M.Sc., Ph.D. Manager, ADR Unit Office of Clinical Trials Therapeutic Products Directorate hoda_eid@hc-sc.gc.ca Overview Clinical
STT ENVIRO CORP. (the Company ) CHARTER OF THE CORPORATE GOVERNANCE AND NOMINATING COMMITTEE. As amended by the Board of Directors on May 10, 2012
STT ENVIRO CORP. (the Company ) CHARTER OF THE CORPORATE GOVERNANCE AND NOMINATING COMMITTEE PURPOSE AND SCOPE As amended by the Board of Directors on May 10, 2012 The primary function of the Committee
BOARD MANUAL. DATE: May 25, 2011 REVISED/REVIEWED: November 26, 2014
BOARD MANUAL SUBJECT: SECTION: Board Processes NUMBER: 2-D-18 APPROVED BY: Board of Directors DATE: May 25, 2011 REVISED/REVIEWED: Table of Contents 1. Recruitment and Selection of New Directors... 2 2.
A responsible approach to clinical trials. Bioethics in action
A responsible approach to clinical trials Bioethics in action What is bioethics? At Novo Nordisk bioethics is the expression used for all ethical issues related to the use of life science technologies
University of Central Florida College of Medicine Industry Relations Policy and Guidelines. Table of Contents
University of Central Florida College of Medicine Industry Relations Policy and Guidelines 1. Introduction and Scope of Policy 2. Statement of Policy Table of Contents 3. Gifts and Individual Financial
TRIAL MASTER FILE- SPONSORED
gsop-06-04 - Management of TMF for ENHT/ WHHT Sponsored CTIMPs Page 1 of 16 Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust TRIAL MASTER
With only modest resources, and within a. Innovation Catalysts and Accelerators The Impact of Ontario Colleges Applied Research
Executive Summary November 2010 Innovation Catalysts and Accelerators The Impact of Ontario Colleges Applied Research At a Glance Through applied research collaborations, Ontario colleges are emerging
POSTGRADUATE EDUCATION COMMITTEE OF COFM REVISED MARCH 2010. PGE Principles/Guidelines
COUNCIL OF ONTARIO FACULTIES OF MEDICINE An affiliate of the Council of Ontario Universities POSTGRADUATE EDUCATION COMMITTEE OF COFM REVISED MARCH 2010 PGE Principles/Guidelines 180 Dundas Street West,
Essential Documents for Clinical Trial Research. Centre for Health Evaluation and Outcome Sciences Manager, Clinical Research Development Office
Essential Documents for Clinical Trial Research Erin Cherban, MSc., CCRP Centre for Health Evaluation and Outcome Sciences Manager, Clinical Research Development Office Document Examples See the following
OFFICE OF THE VICE CHANCELLOR FOR ACADEMIC AFFAIRS. OFFICE OF THE DEAN Org Code: MADNEG
OFFICE OF THE CHANCELLOR STATE OF HAWAI'I UNIVERSITY OF HAWAI'I UNIVERSITY OF HAWAI'I AT MĀNOA OFFICE OF THE VICE CHANCELLOR FOR ACADEMIC AFFAIRS External Advisory Council** Internal Administrative Council**
AMAYA INC. CORPORATE GOVERNANCE, NOMINATING AND COMPENSATION COMMITTEE CHARTER
AMAYA INC. CORPORATE GOVERNANCE, NOMINATING AND COMPENSATION COMMITTEE CHARTER PURPOSE The Corporate Governance, Nominating and Compensation Committee (the Committee ) is a standing committee appointed
Abt Associates Inc. Abt Associates Clinical Trials Comprehensive clinical research services
Abt Associates Inc. Abt Associates Clinical Trials Comprehensive clinical research services Providing a wide range of clinical research services Abt Associates Clinical Trials (AACT) is dedicated to providing
THE NEW YORK TIMES COMPANY AUDIT COMMITTEE CHARTER (Last amended February 21, 2013)
THE NEW YORK TIMES COMPANY AUDIT COMMITTEE CHARTER (Last amended February 21, 2013) Purpose and Responsibilities of the Committee The Board of Directors of The New York Times Company (the Company ) has
University of Toronto Quality Assurance Process (UTQAP)
University of Toronto Quality Assurance Process (UTQAP) Revised version approved by the Ontario Universities Council on Quality Assurance September 21, 2012 Table of Contents 1 Quality Assurance Context
Position Profile Executive Director Skills for Change (SfC)
Position Profile Executive Director Skills for Change (SfC) 1.0 Profile of Skills for Change 1.1 Background Information Since 1982, Skills for Change (SfC) has worked with over 120,000 immigrants and refugees
FIRST COAST HEALTH ALLIANCE, LLC CHARTER AUDIT, FINANCE, AND NETWORK CONTRACTS COMMITTEE
AUDIT, FINANCE, AND NETWORK CONTRACTS COMMITTEE 1. Establishment and Purpose. The Audit, Finance, and Networks Contracts Committee is established by the Board for the purpose of overseeing the integrity
ASSOCIATE DEAN OF NURSING, BYRDINE F. LEWIS CHAIR (Salary Range $130,000 to $160,000)
ASSOCIATE DEAN OF NURSING, BYRDINE F. LEWIS CHAIR (Salary Range $130,000 to $160,000) Job Description: The Associate Dean is the program administrator of the School of Nursing appointed by the Dean of
P SAB. What it is & What it does. Better information for decision making and accountability for Canadian governments
P SAB What it is & What it does Better information for decision making and accountability for Canadian governments The Public Sector Accounting Board of Canada 277 Wellington Street West Toronto, Ontario
CLHIA Submission to the New Brunswick Advisory Committee on Health Benefits Concerning Developing a Drug Plan for Uninsured New Brunswickers
CLHIA Submission to the New Brunswick Advisory Committee on Health Benefits Concerning Developing a Drug Plan for Uninsured New Brunswickers 1 Queen Street East Suite 1700 Toronto, Ontario M5C 2X9 1, rue
Staff Member Signature Date Direct Supervisor Related Mater Health Services Position Description attached. Theme Leader Signature Date.
POSITION DESCRIPTION Mothers and Babies Theme Position Title Division Position Purpose Position Scope Occupational Category and Level Reporting Relationship Review Date Next Review Due, Mothers and Babies
The new EU Clinical Trials Regulation How NHS research and patients will benefit
the voice of the NHS in Europe Briefing September 2014 Issue 19 The new EU Clinical Trials Regulation How NHS research and patients will benefit Who should read this briefing? This briefing will be of
Erie St. Clair Community Care Access Centre Response to Patient First: A Proposal to Strengthen Patient-Centred Health Care in Ontario
Erie St. Clair Community Care Access Centre Response to Patient First: A Proposal to Strengthen Patient-Centred Health Care in Ontario BACKGROUND AND INTRODUCTION The Erie St. Clair CCAC, comprised of
Hollie Goddard Sr. IRB Coordinator McKesson Specialty Health
Hollie Goddard Sr. IRB Coordinator McKesson Specialty Health We are responsible for acquiring, analyzing, and protecting medical information vital to providing quality patient care HIM professionals ensure
BOARD OF DIRECTORS MANDATE
BOARD OF DIRECTORS MANDATE Board approved: May 7, 2014 This mandate provides the terms of reference for the Boards of Directors (each a Board ) of each of Economical Mutual Insurance Company ( Economical
Full-time or part-time upto 1.0 FTE, 4 year fix term Principal Investigator Department of Cardiology Westmead Hospital
Position Description POSITION TITLE Project Manager TYPE OF EMPLOYMENT Full-time or part-time upto 1.0 FTE, 4 year fix term REPORTING TO a) Principal Investigator DIVISION Department of Cardiology COMPANY
3.2.1 Evaluation and approval process for new fields and new programs created from existing and approved University of Ottawa programs
3.2 Protocol for the Expedited Approval of Graduate Programs The Expedited Approval Process requires the submission to the Ontario Universities Council on Quality Assurance of a Proposal Brief. No external
Re: Submission to the Provincial Government on Credit Transfer in Ontario
July 29, 2013 The Honourable Brad Duguid, MPP Minister of Training, Colleges and Universities 3 rd Floor, Mowat Block 900 Bay Street Toronto, Ontario M7A 1L2 Dear Minister: Re: Submission to the Provincial
Business Plan 2014-2015
Business Plan 2014-2015 Table of Contents RHRA Corporate Overview Profile 1 Vision, Mission, Mandate and Values 1 Strategic Priorities and Business Planning Overview 2 Fiscal Year 2014-15 Activities and
The New EU Clinical Trials Regulation: The Good, the Bad, the Ugly
A Full-Service International CRO The New EU Clinical Trials Regulation: The Good, the Bad, the Ugly Dr. Martine Dehlinger-Kremer Vice President, Global Medical and Regulatory Affairs The original intent
Policy Brief: Protecting Privacy in Cloud-Based Genomic Research
Policy Brief: Protecting Privacy in Cloud-Based Genomic Research Version 1.0 July 21 st, 2015 Suggested Citation: Adrian Thorogood, Howard Simkevitz, Mark Phillips, Edward S Dove & Yann Joly, Policy Brief:
REQUEST FOR PROPOSAL Branded Content Marketing and Contest Development to Target International Markets
REQUEST FOR PROPOSAL Branded Content Marketing and Contest Development to Target International Markets Contents Introduction... 1 The RFP Process... 1 Project Timetable... 1 Proposal Submission Guidelines...
KING III CORPORATE GOVERNANCE COMPLIANCE REGISTER
KING III CORPORATE GOVERNANCE REGISTER CHAPTER 1: ETHICAL LEADERSHIP AND CORPORATE CITIZENSHIP NON 1.1. The board should provide effective leadership based on an ethical foundation 1.2. The board should
Clinical trials regulation
Clinical trials regulation The Proposal for a Regulation of the European Parliament and of the Council on Clinical Trials on Medicinal Products for Human Use and Repealing Directive 2001/20/EC an update
The University of North Texas at Dallas Policy Manual
The University of North Texas at Dallas Policy Manual Chapter 6.000 6.020 Academic Program Review Faculty Affairs Policy Statement. UNT Dallas offers high-quality academic programs that are achieved through
Document Title: Research Database Application (ReDA)
Document Title: Research Database Application (ReDA) Document Number: SOP035 Staff involved in development: Job titles only Document author/owner: Directorate: Department: For use by: RM&G Manager, R&D
NORWICH CLINICAL TRIALS UNIT OVERVIEW
NORWICH CLINICAL TRIALS UNIT OVERVIEW This document provides an overview of the Norwich Clinical Trials Unit. Sections 1 to 3 describe the Norwich Clinical Trials Unit remit and structure. Section 4 gives
2016/2017 National New Investigator Award Submission Guidelines
2016/2017 National New Investigator Award Submission Guidelines (Fall 2015 Competition) June 2015 Table of Contents A. General Information... 1 1) Our Vision... 1 2) Our Mission.... 1 3) Application Submission
14 New Greater Toronto Region Global Investment Attraction Agency (Newco)
Clause 14 in Report No. 17 of Committee of the Whole was adopted, without amendment, by the Council of The Regional Municipality of York at its meeting held on November 19, 2015. 14 New Greater Toronto